参考文献/References:
[1] Humbert M,Kovacs G,Hoeper MM,et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension[J]. Eur Heart J,2022,43(38):3618-3731.
[2] Hemnes AR,Kiely DG,Cockrill BA,et al. Statement on pregnancy in pulmonary hypertension from the pulmonary vascular research institute[J]. Pulm Circ,2015,5(3):435-465.
[3] Kang Y,Jiang X. Pregnancy outcomes and risk factors of serious cardiovascular adverse events in pregnant women with pulmonary hypertension[J]. Int J Surg,2024,110(3):1850-1852.
[4] Chen Y,Zhou D,Xiong M,et al. Prediction and prognosis of adverse maternal and foetal/neonatal outcomes in pulmonary hypertension:an observational study and nomogram construction[J]. Respir Res,2022,23(1):314.
[5] Ma R,Gao H,Cui J,et al. Pregnancy feasibility in women with mild pulmonary arterial hypertension:a systematic review and meta-analysis[J]. BMC Pregnancy Childbirth,2023,23(1):427.
[6] Fan C,Liu X,Liu R,et al. Pregnancy conditions and outcomes of Chinese women with mild,moderate and severe pulmonary arterial hypertension[J]. Hypertens Res,2024,47(9):2561-2573.
[7] Miao H,Chen Y,Wang C,et al. Pregnancies in women with moderate and severe pulmonary hypertension remain challenging:A single-center experience in East China[J]. Int J Gynecol Obste,2022,157(1):140-148.
[8] Sliwa K,van Hagen IM,Budts W,et al. Pulmonary hypertension and pregnancy outcomes:data from the Registry Of Pregnancy and Cardiac Disease ( ROPAC ) of the European Society of Cardiology[J]. Eur J Heart Fail,2016,18(9):1119-1128.
[9] Chen W,Luo J,Chen J,et al. Effect of multidisciplinary team (MDT) centred on pregnant women with pulmonary hypertension on treatment and outcomes of pregnancy[J]. BMC Pulm Med,2023,23(1):62.
[10] Zhang Q,Zhu F,Shi G,et al. Maternal outcomes among pregnant women with congenital heart disease-associated pulmonary hypertension[J]. Circulation,2023,147(7):549-561.
[11] Liu Y,Li H,Li Y,et al. Outcomes of pregnancy in women with different types of pulmonary hypertension[J]. BMC Cardiovasc Disord,2023,23(1):391.
[12] Wang W,Wang L,Feng P,et al. Real-world in-hospital outcomes and potential predictors of heart failure in primigravid women with heart disease in Southwestern China[J]. BMC Pregnancy Childbirth,2020,20(1):372.
[13] Potnuru PP,Jefferies H,Lei R,et al. Maternal pulmonary hypertension and cardiopulmonary outcomes during delivery hospitalization in the United States:a nationwide study from 2016 -2020[J]. Pregnancy Hypertens,2024,38:101170.
[14] Agrawal A,Bajaj S,Bhagat U,et al. Cardiovascular complications with delivery hospitalizations in patients with pulmonary hypertension:a nationwide study from 2011 to 2020[J]. JAHA,2024,13(11):e031632.
[15] Low T,Guron N,Ducas R,et al. Pulmonary arterial hypertension in pregnancy—a systematic review of outcomes in the modern era[J]. Pulm Circ,2021,11(2):1-9.
[16] Roos-Hesselink J,Baris L,Johnson M,et al. Pregnancy outcomes in women with cardiovascular disease:evolving trends over 10 years in the ESC Registry Of Pregnancy And Cardiac disease(ROPAC)[J]. Eur Heart J,2019,40(47):3848-3855.
[17] Preston IR,Howard LS,Langleben D,et al. Management of pulmonary hypertension in special conditions[J]. Eur Respir J,2024,64(4):2401180.
[18] Liu Y,Li Y,Zhang J,et al. Pregnancy outcomes of women with Eisenmenger syndrome:a single-center study[J]. Int J Cardiol ,2023,374:35-41.
[19] Liu Y,Li Y,Zhang J,et al. Maternal and fetal outcomes of pregnant women with pulmonary arterial hypertension associated with congenital heart disease in Beijing,China:A retrospective study[J]. Pulm Circ,2022,12(2):e12079.
[20] Lv C,Wu L,Liao G,et al. Maternal and fetal/neonatal outcomes of pregnancies complicated by pulmonary hypertension:a retrospective study of 154 patients[J]. Clinics,2023,78:100194.
[21] Angelopoulos A,Farrell R. PH professional network:genetic counseling and pulmonary arterial hypertension[J]. Adv Pulm Hypertens,2021,20(5):164-167.
[22] van Giersbergen PLM,Halabi A,Dingemanse J. Pharmacokinetic interaction between bosentan and the oral contraceptives norethisterone and ethinyl estradiol[J]. Int J Clin Pharmacol Ther,2006,44(3):113-118.
[23] Lakshminrusimha S,Abman SH. Oxygen targets in neonatal pulmonary hypertension[J]. Clin Perinatol,2024,51(1):77-94.
[24] 中华医学会呼吸病学分会肺栓塞与肺血管病学组,中国医师协会呼吸医师分会肺栓塞与肺血管病工作委员会,全国肺栓塞与肺血管病防治协作组,等. 中国肺动脉高压诊断与治疗指南(2021版)[J]. 中华医学杂志,2021,101(1):11-51.
[25] van der Zande JA,Greutmann M,Tobler D,et al. Diuretics in pregnancy:data from the ESC registry of pregnancy and cardiac disease (ROPAC)[J]. Eur J Heart Fail,2024,26(7):1561-1570.
[26] Regitz-Zagrosek V,Roos-Hesselink JW,Bauersachs J,et al. 2018 ESC guidelines for the management of cardiovascular diseases during pregnancy[J]. Eur Heart J,2018,39(34):3165-3241.
[27] S?rbye IK,Haualand R,Wiull H,et al. Maternal beta-blocker dose and risk of small-for gestational-age in women with heart disease[J]. Acta Obstet Gynecol Scand,2022,101(7):794-802.
[28] 中华医学会妇产科学分会产科学组.妊娠期及产褥期静脉血栓栓塞症预防和诊治专家共识[J].中华妇产科杂志,2021,56(4):236-243.
[29] 杨彩华,杨龙娜,李小波. 妊娠早期暴露低剂量华法林钠片后致胎儿畸形2例分析[J].中国药物警戒,2023,20(11):1286-1289.
[30] Wang T,Lu J,Li Q,et al. Rapid titration of intravenous treprostinil to treat severe pulmonary arterial hypertension postpartum:a retrospective observational case series study[J]. Anesth Analg ,2019,129(6):1607-1612.
[31] Perisetla N,Miranda C,Louis J,et al. Inhaled epoprostenol via high-flow nasal cannula and intravenous treprostinil for management of severe pulmonary arterial hypertension during cesarean delivery with epidural anesthesia:a case report[J]. Int J Obstet Anesth ,2024,61:104295.
[32] Hoeper MM,Badesch DB,Ghofrani HA,et al. Phase 3 trial of sotatercept for treatment of pulmonary arterial hypertension[J]. N Engl J Med,2023,388(16):1478-1490.
[33] Ming Y,Wu Z,Wu Z,et al. Effects of different anesthesia methods on maternal and neonatal outcomes in pregnant patients with pulmonary arterial hypertension:a meta-analysis[J]. Arch Gynecol Obstet,2022,306(1):7-15.
[34] 中华医学会妇产科学分会产科学组. 妊娠合并心脏病的诊治专家共识（2016）[J].中华妇产科杂志,2016,51(6):401-409.
[35] Kamp JC,von Kaisenberg C,Greve S,et al. Pregnancy in pulmonary arterial hypertension:Midterm outcomes of mothers and offspring[J]. J Heart Lung Transplant,2021,40(3):229-233.
相似文献/References:
[1]孟晓冬,单福祥,综述,等.肺动脉高压治疗进展[J].心血管病学进展,2016,(3):319.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.028]
MENG Xiaodong,SHAN Fuxiang,WANG Yanhui.Advances in Research of Pulmonary Hypertension[J].Advances in Cardiovascular Diseases,2016,(6):319.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.028]
[2]张艺韬,综述,曾伟杰,等.左心疾病相关肺动脉高压流行病学[J].心血管病学进展,2016,(4):333.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.002]
ZHANG Yitao,ZENG Weijie,CHENG Kanglin.Epidemiology of Pulmonary Hypertension due to Left Heart Disease[J].Advances in Cardiovascular Diseases,2016,(6):333.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.002]
[3]汪汉,刘英杰,王燕凤.长链非编码RNA与肺动脉高压[J].心血管病学进展,2019,(6):898.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.015]
WANG Han,LIU Yingjie,WANG Yanfeng.Long Non-coding RNA in Pulmonary Arterial Hypertension[J].Advances in Cardiovascular Diseases,2019,(6):898.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.015]
[4]汪汉 邓祁 刘英杰.系统性红斑狼疮相关肺动脉高压的诊断、治疗及预后[J].心血管病学进展,2019,(8):1142.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.018]
WANG Han,DENG Qi,LIU Yingjie.Diagnosis,Treatment and Prognosis of Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus[J].Advances in Cardiovascular Diseases,2019,(6):1142.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.018]
[5]段宇 贾静 步睿 李涛 韦宏.急性伊洛前列素吸入对肺动脉高压患者右心室功能的影响[J].心血管病学进展,2019,(9):1319.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.034]
DUAN Yu,JIA Jing,BU Rui,et al.The Effect of Acute Iloprost Inhalation on Right Ventricular Function in Pulmonary Arterial Hypertension[J].Advances in Cardiovascular Diseases,2019,(6):1319.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.034]
[6]查玉杰 何庆.肺动脉高压发生发展中的相关因子[J].心血管病学进展,2020,(2):192.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.024]
ZHA YujieHE Qing.The Relevant Factors in the Development of Pulmonary Hypertension[J].Advances in Cardiovascular Diseases,2020,(6):192.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.024]
[7]朱珊英,朱国斌.肺动脉高压发病机制新进展[J].心血管病学进展,2020,(3):292.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.019]
ZHU Shanying,ZHU Guobin.Pathogenesis of Pulmonary Hypertension[J].Advances in Cardiovascular Diseases,2020,(6):292.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.019]
[8]韩柯,孟祥光,赵育洁.趋化因子及其受体在肺动脉高压中的研究进展[J].心血管病学进展,2020,(3):296.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.020]
HAN Ke,MENG Xiangguang,ZHAO Yujie.Chemokines and Their Receptors in Pulmonary Arterial Hypertension[J].Advances in Cardiovascular Diseases,2020,(6):296.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.020]
[9]刘超 曲杰 王明娟 徐倩 范彦芳 周晓慧 单伟超.肺动脉高压对扩张型心肌病预后的影响[J].心血管病学进展,2020,(4):424.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.023]
LIU ChaoQU JieWANG MingjuanXU QianFAN YanfangZHOU XiaohuiSAN Weichao.The Effect of Pulmonary Hypertension on the Prognosis of Dilated Cardiomyopathy[J].Advances in Cardiovascular Diseases,2020,(6):424.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.023]
[10]向杰 刘明鑫 张伟 黄从新.基于生物信息学分析探究肺动脉高压关键基因和通路[J].心血管病学进展,2020,(4):428.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.024]
Xiang JieLiu MingxinZhang WeiHuang Congxin.Bioinformatics Analysis of Key Genes and Pathways in Pulmonary Arterial Hypertension[J].Advances in Cardiovascular Diseases,2020,(6):428.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.024]
[11]房晨鹂?铁馨 刘元汉.妊娠合并肺动脉高压的发病机制及性激素的作用[J].心血管病学进展,2021,(7):625.[doi:10.16806/j.cnki.issn.1004-3934.2021.07.012]
FANG Chenli,TIE Xin,LIU Yuanhan,et al.The Pathogenesis of Pregnancy with Pulmonary Hypertension and the Role of Sex Hormones[J].Advances in Cardiovascular Diseases,2021,(6):625.[doi:10.16806/j.cnki.issn.1004-3934.2021.07.012]